Synthesis of combretastatin A-2 prodrugs

Organic compounds -- part of the class 532-570 series – Organic compounds – Phosphorus esters

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07105695

ABSTRACT:
The original synthesis of combretastatin A-2 (1a) was modified to provide an efficient scale-up procedure for obtaining this antineoplastic stilbene. Subsequent conversion to a useful prodrug was accomplished by phosphorylation employing in situ formation of dibenzylchlorophosphite followed by cleavage of the benzyl ester protective groups with bromotrimethylsilane to afford phosphoric acid intermediate 11. The latter was immediately treated with sodium methoxide to complete a practical route to the disodium phosphate prodrug (2a). The phosphoric acid precursor (11) of phosphate 2a was employed in a parallel series of reactions to produce a selection of metal and ammonium cation prodrug candidates. Each of the phosphate salts (2a–q) was evaluated with respect to relative solubility behavior, cancer cell growth inhibition, and antimicrobial activity.

REFERENCES:
patent: WO 99/35150 (1999-07-01), None
patent: WO 02/006279 (2002-01-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Synthesis of combretastatin A-2 prodrugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthesis of combretastatin A-2 prodrugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis of combretastatin A-2 prodrugs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3586898

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.